Cornerstone Select Advisors’s AbbVie ABBV Stock Holding History

Cornerstone Select Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.33M	Buy	13,222 +1,973	+18%	+$424K	1.4%	19
2026 Q1	$2.45M	Buy	11,249 +328	+3%	+$72.8K	1.53%	20
2025 Q4	$2.5M	Buy	10,921 +34	+0.3%	+$7.75K	1.73%	14
2025 Q3	$2.52M	Buy	10,887 +962	+10%	+$196K	1.85%	13
2025 Q2	$1.84M	Sell	9,925 -653	-6%	-$121K	1.62%	21
2025 Q1	$2.22M	Buy	10,578 +557	+6%	+$108K	2.1%	10
2024 Q4	$1.78M	Buy	+10,021	New	+$1.84M	1.72%	13

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cornerstone Select Advisors's ABBV Position: Q2 2026 in Review

Cornerstone Select Advisors increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $424K and bringing the position to 13,222 shares worth $3.33M. The position accounts for 1.4% of the portfolio, ranked #19.

Cornerstone Select Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cornerstone Select Advisors held 13,222 shares of AbbVie worth $3.33M as of Q2 2026.
Cornerstone Select Advisors bought 1,973 AbbVie shares in Q2 2026, an estimated $424K.
AbbVie made up 1.4% of Cornerstone Select Advisors's portfolio in Q2 2026, its #19 holding.
Cornerstone Select Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cornerstone Select Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.